← Eichor
Condition: Multiple Sclerosis Relapse Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Multiple Sclerosis Relapse

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
NA · 1 location(s) · Cionic, Inc. · NCT05964829A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of a New Subcuta
Phase 1 · 12 location(s) · Hoffmann-La Roche · NCT07667322Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis
Phase 4 · 1 location(s) · Northwestern University · NCT07225361Prospective Evaluation of Sequencing From antiCD-20 Therapies to Ozanimod
Phase 4 · 3 location(s) · University of Colorado, Denver · NCT06529406Development of Camera Based Gait Quality Measure for Persons With Multiple Sclerosis
Phase N/A · 1 location(s) · Shirley Ryan AbilityLab · NCT06516458A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell ( CAR-T) Therapy in Subjects With Non-relapsing and Progressive Fo
Phase 1 · 1 location(s) · Stanford University · NCT06138132Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
Phase 3 · 22 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT04047628Hyperpolarized Carbon Metabolic Imaging in Multiple Sclerosis
Phase 2 · 1 location(s) · Ari Green · NCT07510607Study to Assess Effects of Ublituximab in Pediatric Participants With Relapsing Forms of Multiple Sclerosis
Phase 2/Phase 3 · 2 location(s) · TG Therapeutics, Inc. · NCT07220252Non-inferiority Study of Rituximab Compared to Ocrelizumab in Relapsing MS
Phase 3 · 1 location(s) · Amsterdam UMC, location VUmc · NCT05834855Motor Learning of Fall Resistant Skills Through Slip and Trip Exposure in Multiple Sclerosis
NA · 1 location(s) · Georgia State University · NCT06919900A Study Evaluating the Presence and Concentration of BRIUMVI™ (Ublituximab) in Breast Milk
Phase N/A · 5 location(s) · TG Therapeutics, Inc. · NCT06143514Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)
Phase N/A · 7 location(s) · Biogen · NCT05658497Retinal Neuro-vascular Coupling in Patients With Multiple Sclerosis
NA · 1 location(s) · Medical University of Vienna · NCT03401879"Selfie" Videos: A Novel, Patient-centered, Comprehensive Approach to Measuring Function in MS
Phase N/A · 1 location(s) · University of California, San Francisco · NCT07222618Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS
NA · 1 location(s) · Shirley Ryan AbilityLab · NCT06390930A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 1
Phase 2 · 17 location(s) · ModernaTX, Inc. · NCT06735248Imaging the Interplay Between Axonal Damage and Repair in Multiple Sclerosis
Phase N/A · 1 location(s) · University Hospital, Basel, Switzerland · NCT05177523Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relap
Phase 3 · 33 location(s) · Bristol-Myers Squibb · NCT06408259Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/B Cell Maturation Antigen （CD19/BCMA） in
EARLY_Phase 1 · 1 location(s) · Tianjin Huanhu Hospital · NCT06939166Understanding the 'Durable Effect' Concept of B-cell Modulating Therapies
Phase N/A · 1 location(s) · Heinrich-Heine University, Duesseldorf · NCT06586177Exploring the Efficacy and Safety of Ofatumumab in Patients With Relapsing Multiple Sclerosis (RMS) and Its Impact on Se
Phase N/A · 1 location(s) · Third Affiliated Hospital, Sun Yat-Sen University · NCT07353216A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Mult
Phase N/A · 91 location(s) · TG Therapeutics, Inc. · NCT06433752Fatigue Alleviation Through Neuromodulating Therapy in Multiple Sclerosis
NA · 1 location(s) · Danish Research Centre for Magnetic Resonance · NCT06569550MS-ResearchBiomarkerS
Phase N/A · 1 location(s) · Cedars-Sinai Medical Center · NCT05204459Postoperative Relapses in MS Patients
Phase N/A · 2 location(s) · University of Athens · NCT04237675Biomarkers of aHSCT
Phase N/A · 1 location(s) · Sheffield Teaching Hospitals NHS Foundation Trust · NCT06195800An Open-label Study to Assess the Safety, Efficacy, and Cellular Kinetics of YTB323 in Relapsing Multiple Sclerosis
Phase 1/Phase 2 · 18 location(s) · Novartis Pharmaceuticals · NCT06617793ELIOS - Investigational Biomarkers to Track Disease Modification in Active RRMS
Phase 4 · 14 location(s) · Novartis Pharmaceuticals · NCT06733922A Single-Center Study to Characterize the Safety and Efficacy of Ublituximab in Older Adults With Relapsing Forms of Mul
Phase N/A · 1 location(s) · Neurology Center of New England P.C. · NCT06681623
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.